CytoSorbents Corporation · NASDAQ:CTSO

CytoSorbents — Fact Sheet (2023)

2 slides from CytoSorbents's fact sheet, 2023

  1. Slide 1: Organ Perfusion: First CE certified product for cytokine removal

    Demonstrated removal of inflammatory mediators: IL-6, IL-8, TNF-alpha… Preclinical data proves the efficacy in Steen and Belzer solutions First CE certified product for cytokine removal in ex-vivo organ perfusion Contact us today to learn more about the new ECOS-300CY® Therapy Organ Perfusion suppor

  2. Slide 2: Organ transplant trends and introducing ECOS-300CY cytokine adsorption

    Organ transplant trends Introducing ECOS-300CY® cytokine adsorption Increasing number of needed organs – decreasing quality of available organs Versatile application in different organs, procedures and platforms Globally, more than 125,000 organs are transplanted every year. While a transplantation

CytoSorbents — Fact Sheet (2023) on 6ix